CSIMarket
 


Lemaitre Vascular Inc   (LMAT)
Other Ticker:  
 
 

Lemaitre Vascular Inc Accounts Receivables Turnover Ratio from the forth quarter 2023 to the forth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Lemaitre Vascular Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the forth quarter 2023 to a ratio of 7.67, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the forth quarter 2023. Average collection period, for Lemaitre Vascular Inc 's accounts receivable remained unchanged at 48 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 93 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1088, from overall ranking in the third quarter 2023 at 1697.

What is Receivable Turnover Ratio?
What is Lemaitre Vascular Inc Selling?


What is Receivable Turnover Ratio?




LMAT Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Receivable Change 13.72 % 18.85 % 22.58 % 18.61 % 12.27 %
Y / Y Revenue Change 19.82 % 19.95 % 18.95 % 18.99 % 3.67 %
Receivable Turnover Ratio (TTM) 7.67 7.57 7.55 7.6 7.6
LMAT's Total Ranking # 1088 # 1697 # 1902 # 1859 # 1493
Average receivable collection period 48 48 48 48 48
Seq. Receivable Change 4.95 % -9.56 % 4.1 % 15.09 % 9.68 %
Seq. Revenue Change 4.82 % -6.53 % 6.4 % 14.95 % 4.93 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 26
Healthcare Sector # 94
Overall Market # 1088

Receivable Turnover Ratio Statistics
High Average Low
7.78 7.14 6.53
(Mar 31 2022)   (June 30. 2014)






Financial Statements
Lemaitre Vascular Inc 's Accounts Receivable $ 25 Millions Visit LMAT's Balance sheet
Lemaitre Vascular Inc 's Sales TTM $ 193 Millions Visit LMAT's Income Statement
Where are LMAT's Sales coming from? Visit LMAT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LMAT's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for LMAT's Competitors
Receivables Turnover Ratio for LMAT's Suppliers
Accounts Receivables Turnover Ratio for LMAT's Customers

You may also want to know
LMAT's Growth Rates LMAT's Roa LMAT's Inventory Turnover Ratio LMAT's Dividend Comparisons
LMAT's Profitability Ratios LMAT's Roi LMAT's Asset Turnover Ratio LMAT's Dividend Growth
LMAT's Valuation Ratios LMAT's Roe LMAT's Financial Strength Ratios LMAT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Editas Medicine Inc   20.64 $ 78.123  Millions$ 3.784  Millions
Cue Health Inc   20.01 $ 70.936  Millions$ 3.545  Millions
Innovage Holding Corp   19.58 $ 720.796  Millions$ 36.806  Millions
Kiniksa Pharmaceuticals ltd   19.17 $ 270.259  Millions$ 14.095  Millions
Neptune Wellness Solutions Inc   18.45 $ 39.115  Millions$ 2.120  Millions
Valneva Se  18.11 $ 172.159  Millions$ 9.509  Millions
Ensysce Biosciences Inc   17.55 $ 3.385  Millions$ 0.193  Millions
Biofrontera Inc   17.48 $ 116.349  Millions$ 6.657  Millions
Halozyme Therapeutics Inc   17.02 $ 829.253  Millions$ 48.721  Millions
Recursion Pharmaceuticals Inc   15.69 $ 44.575  Millions$ 2.842  Millions
Owens and Minor inc  15.24 $ 10,333.161  Millions$ 677.813  Millions
Neuroone Medical Technologies Corporation  14.87 $ 2.816  Millions$ 0.189  Millions
Chemed Corporation  14.52 $ 2,264.417  Millions$ 155.918  Millions
Icu Medical Inc  14.46 $ 2,259.126  Millions$ 156.262  Millions
Patterson Companies Inc   14.11 $ 6,565.239  Millions$ 465.318  Millions
Corcept Therapeutics Inc  13.70 $ 482.375  Millions$ 35.215  Millions
Theralink Technologies Inc   13.67 $ 0.511  Millions$ 0.037  Millions
Protalix Biotherapeutics inc   13.39 $ 65.494  Millions$ 4.890  Millions
Exact Sciences Corporation  13.25 $ 2,532.479  Millions$ 191.179  Millions
Utah Medical Products Inc  12.39 $ 50.658  Millions$ 4.088  Millions
Teladoc Health Inc   12.18 $ 2,602.415  Millions$ 213.613  Millions
Caribou Biosciences Inc   12.12 $ 34.477  Millions$ 2.844  Millions
Siga Technologies Inc  11.78 $ 139.917  Millions$ 11.881  Millions
Integrated Biopharma Inc  11.42 $ 48.833  Millions$ 4.275  Millions
Option Care Health Inc   11.09 $ 4,302.223  Millions$ 388.081  Millions
National Research Corporation  11.05 $ 148.580  Millions$ 13.445  Millions
National Healthcare Corp  10.98 $ 1,141.544  Millions$ 104.011  Millions
Revance Therapeutics Inc   10.95 $ 234.040  Millions$ 21.377  Millions
Biontech Se  10.68 $ 4,277.280  Millions$ 400.624  Millions
Arrowhead Pharmaceuticals Inc   10.29 $ 181.740  Millions$ 17.670  Millions

Date modified: 2024-03-01T04:50:28+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com